Truveris
New York
About Truveris
Truveris brings transparency to the prescription drug ecosystem through data-driven innovations. Truveris’ platform offers customers – from the individual patient to employers, retailers, pharmacy benefits stakeholders, and manufacturers – the data and insights they need to effectively and efficiently manage rising costs and market access challenges. Based in Manhattan, Truveris is backed by Canaan Partners, New Leaf Venture Partners, Tribeca Venture Partners, New Atlantic Ventures and First Round Capital.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $69.0M
- Funding stage: Late Stage Venture
- Last round: Series E (May 2024)
- Website: truveris.com
- Phone: 800-430-1430
Industries & Categories
Health Care, Information Technology, SaaS, Wellness
Social Profiles
Canonical: https://fsome.com/organization/truveris-115698 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.